UPDATE: Piper Jaffray Initiates Coverage on GW Pharmaceuticals on Expected Attractive Returns
November 27, 2013 at 10:46 AM EST
In a report published Wednesday, Piper Jaffray analyst Joshua E. Schimmer initiated coverage on GW Pharmaceuticals PLC (NASDAQ: GWPH ) with an Overweight rating and $73.00 price target. In the report, Piper Jaffray noted, “We are initiating, resuming or assuming coverage on 16 biotechnology companies. We believe the outlook for
